Cryoport, Inc.

Equities

CYRX

US2290503075

Air Freight & Logistics

Real-time Estimate Cboe BZX 10:56:43 2024-04-16 am EDT 5-day change 1st Jan Change
16.88 USD -0.82% Intraday chart for Cryoport, Inc. -10.25% +9.10%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Investors on -2- DJ
UBS Adjusts Cryoport Price Target to $17 From $14.50, Maintains Neutral Rating MT
Tranche Update on Cryoport, Inc.'s Equity Buyback Plan announced on March 11, 2022. CI
Needham Trims Price Target on Cryoport to $18 From $19, Keeps Buy Rating MT
Transcript : Cryoport, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Cryoport Q4 Net Loss Widens, Revenue Falls; Issues Guidance MT
Earnings Flash (CYRX) CRYOPORT Posts Q4 Revenue $57.3M, vs. Street Est of $58.4M MT
Cryoport, Inc. Announces Goodwill Impairment for the Quarter Ended December 31, 2023 CI
Cryoport, Inc. Provides Revenue Guidance for the Year 2024 CI
Cryoport, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
What Alabama ruling means for patients with frozen embryos: one woman's story RE
Cryoport, Inc. Announces Transition of Edward Zecchini from the Board of Directors to Sr. Vice President - Chief Digital & Technology Officer CI
Needham Adjusts Cryoport's Price Target to $19 From $18, Maintains Buy Rating MT
UBS Ups Price Target on Cryoport to $14.50 From $13.50, Maintains Neutral Rating MT
Cryoport, Nippon Express Form Partnership to Offer Temperature-Controlled Supply Chain Services MT
Cryoport, Inc. and Nippon EXPRESS HOLDINGS, Inc. Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services CI
Cryoport Acquires Bluebird Express MT
Cryoport, Inc. acquired Bluebird Express LLC for $10.2 million. CI
UBS Cuts Cryoport Price Target to $13.50 From $15, Maintains Neutral Rating MT
Transcript : Cryoport, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Tranche Update on Cryoport, Inc.'s Equity Buyback Plan announced on March 11, 2022. CI
Cryoport, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (CYRX) CRYOPORT Posts Q3 Revenue $56.2M, vs. Street Est of $55.2M MT
Cryoport, Inc. Provides Revenue Guidance for the Year 2023 CI
Cryoport Buys Tec4med Lifescience; Shares Rise MT
Chart Cryoport, Inc.
More charts
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
17.02 USD
Average target price
18.33 USD
Spread / Average Target
+7.72%
Consensus